Symbol Lookup
Company Quote
Last Price 1.11 (11.23.09 5:20 PM EST)
Change (%)     +0.08 (+7.77%)
Volume 523,390
Open 1.05
Previous Close 1.03
Day High 1.15
Day Low 1.02
Bid 1.09 x 700
Ask 1.12 x 5400
   
Chart
Stock Data
Average Volume 538,988
Shares Outstanding 88.66M
Market Cap 98.4M
Year High 1.53
Year Low 0.15
Earnings Per Share -0.11
P/E Ratio -10.1
Dividend N/A
Yield N/A
   
Related Companies
Symbol Last Change (%)
DYSOF 0.89 +0.00 (+0.00)
IDRA 5.00 +0.17 (+3.52%)
SPHRF 0.54 -0.01 (-0.93%)
RVX 2.69 -0.10 (-3.58%)
SNMX 3.49 +0.00 (+0.00)
HBIO 3.67 +0.02 (+0.55%)
RVXCF 2.50 -0.12 (-4.73%)
ARRY 1.94 -0.09 (-4.43%)
News: ENMD
Mon, Nov 16, 2009
Better Than Expected Retail Sales Lifts Markets - MarketMinute.com Mar...
EntreMed's ENMD-2076 active in solid and hematological cancers - theflyonthewall.com
EntreMed Inc. (ENMD) Posts Break-Even Q3 EPS, 4c Better Y/Y - StreetInsider
Sat, Nov 07, 2009
Why We Love Wild Penny Stocks - Fool.com Headlines
Mon, Nov 02, 2009
The Best Stocks for the Next 4 Years - Fool.com Headlines
Blogs: ENMD
Wed, Jun 18, 2008
EntreMed Inc. (ENMD) Announces Seasoned VP to Assist in Business Development Initiatives - Stock Market News & ...
Conference Calls for ENMD
12/02/08 Special Conference  
EntreMed to Present at the New York Society of Security Analysts Industry Conference 
Archive for ENMD
08/12/08 800-418-7236  
03/27/08 Special Conference  
EntreMed, Inc. at BioCentury Publications Inc./Thomson Financial: Future Leaders in the Biotech Industry Conference 
Archive for ENMD
03/13/08 800-418-7236  
02/12/08 Special Conference  
EntreMed to Present at BIO CEO and Investor Conference 
Archive for ENMD
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs
Go
track your portfolio
CLOSE WINDOW  
close window
E-mail Article to a Friend